Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bruno Wohlschlegel Insider Profile
4 Followers
Bruno Wohlschlegel, Chief Executive Officer at APONTIS PHARMA AG, holds ― shares in APONTIS PHARMA AG (Ticker: DE:APPH). Most recently, Bruno Wohlschlegel Bought €1,000 shares of APONTIS PHARMA AG on May 14, 2024 for an estimated value of 8.88K.
Bruno Wohlschlegel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Bruno Wohlschlegel does not currently own shares as a corporate insider.
A breakdown of Bruno Wohlschlegel's holdings
Insider Roles
Chief Executive Officer
Roles that Bruno Wohlschlegel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Bruno Wohlschlegel
Bruno Wohlschlegel's Trading History
List of latest transactions for each holding click on a transaction to see Bruno Wohlschlegel's performance on stock
You May Also Like
Bruno Wohlschlegel insider profile FAQ
What is the percentage of profitable transactions made by Bruno Wohlschlegel?
The percentage of profitable transactions made by Bruno Wohlschlegel is ―.
What is the average return per transaction made by Bruno Wohlschlegel?
The average return per transaction made by Bruno Wohlschlegel is ―.
What stocks does Bruno Wohlschlegel hold?
Bruno Wohlschlegel holds: DE:APPH stocks.
What was Bruno Wohlschlegel’s latest transaction?
Bruno Wohlschlegel latest transaction was an Informative Buy of €8.88K.
What was Bruno Wohlschlegel's most profitable transaction?
Bruno Wohlschlegel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Bruno Wohlschlegel's role in APONTIS PHARMA AG?
Bruno Wohlschlegel's role in APONTIS PHARMA AG is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.